Wird geladen...
Response of factor X deficiency to darutumumab in the treatment of AL amyloidosis: a novel finding
We report a case of progressive light-chain amyloidosis (otherwise known as AL amyloidosis) with acquired factor X (aFX) deficiency with a complete haematological response and rapid normalisation of FX levels following daratumumab monotherapy. To our knowledge, this is the first case report document...
Gespeichert in:
| Veröffentlicht in: | BMJ Case Rep |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8030679/ https://ncbi.nlm.nih.gov/pubmed/33827877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-240631 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|